| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,134 |
10,630 |
$676K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,092 |
11,100 |
$519K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,635 |
3,524 |
$304K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,411 |
3,191 |
$295K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,241 |
2,952 |
$263K |
| 87428 |
|
3,608 |
3,374 |
$261K |
| 87634 |
|
3,014 |
2,805 |
$190K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15,039 |
5,228 |
$162K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,528 |
1,484 |
$136K |
| 99429 |
|
4,164 |
4,049 |
$136K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,402 |
2,201 |
$115K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,395 |
2,278 |
$75K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,021 |
1,006 |
$63K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
8,337 |
6,875 |
$62K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
589 |
572 |
$56K |
| 99383 |
|
475 |
469 |
$45K |
| 99381 |
|
484 |
476 |
$41K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
379 |
374 |
$34K |
| 90461 |
|
3,562 |
3,000 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,451 |
1,331 |
$22K |
| 99382 |
|
222 |
220 |
$21K |
| 99050 |
|
872 |
835 |
$11K |
| 92567 |
|
719 |
683 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
606 |
298 |
$9K |
| 90677 |
|
144 |
140 |
$7K |
| 99384 |
|
70 |
66 |
$7K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
467 |
457 |
$6K |
| 92551 |
|
755 |
740 |
$2K |
| 96160 |
|
885 |
859 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
112 |
111 |
$2K |
| 88720 |
|
322 |
293 |
$1K |
| 17250 |
|
12 |
12 |
$859.86 |
| 97169 |
|
24 |
24 |
$590.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
12 |
$315.40 |
| 87807 |
|
12 |
12 |
$138.38 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
13 |
$126.68 |
| 90686 |
|
1,450 |
1,421 |
$83.19 |
| 99173 |
|
2,279 |
2,228 |
$17.50 |
| 90648 |
|
2,322 |
2,281 |
$0.04 |
| 90734 |
|
128 |
123 |
$0.03 |
| 90651 |
|
178 |
173 |
$0.02 |
| 90723 |
|
1,727 |
1,694 |
$0.01 |
| 90633 |
|
1,028 |
1,010 |
$0.01 |
| 90680 |
|
1,562 |
1,530 |
$0.00 |
| 90716 |
|
433 |
422 |
$0.00 |
| 90696 |
|
136 |
135 |
$0.00 |
| 90670 |
|
2,298 |
2,251 |
$0.00 |
| 90710 |
|
104 |
104 |
$0.00 |
| 90707 |
|
443 |
433 |
$0.00 |
| 90700 |
|
371 |
366 |
$0.00 |
| 90715 |
|
52 |
49 |
$0.00 |